Phase I Dose Escalation of Oral BAY1161909 in Combination With Intravenous Paclitaxel
Clinical trial NCT02138812 · TERMINATED
Trial details
- NCT number
- NCT02138812
- Sponsor
- Bayer
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-05-09
- Primary completion
- 2017-04-28
- Enrollment
- 69
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.